While hypoxia-exposure activates hepatic- and pulmonary fibroblasts, opposite effects have been observed in dermal or cancer-associated fibroblasts, indicating that the anti-fibrotic properties of YC-1 in the peritoneum cannot necessarily be extrapolated to comparable effects in other fibrotic disorders39–42. The gene discussed is RBMS1; the disease is cancer.